Severe Thrombocytopenia Two Weeks Following Immunization with the Janssen Ad26.CoV2.S Vaccine

Immune thrombocytopenia (ITP) has been associated with immunizations with various proposed mechanisms, including overactivation of the immune system and production of antibodies against circulating platelets. ITP has also been associated with several viral infections, including HCV, HIV, and most re...

Full description

Saved in:
Bibliographic Details
Main Authors: Bana Antonios, Markie Zimmer, Emma Herrman, Ramona Berghea
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Case Reports in Hematology
Online Access:http://dx.doi.org/10.1155/2022/7208401
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554740048723968
author Bana Antonios
Markie Zimmer
Emma Herrman
Ramona Berghea
author_facet Bana Antonios
Markie Zimmer
Emma Herrman
Ramona Berghea
author_sort Bana Antonios
collection DOAJ
description Immune thrombocytopenia (ITP) has been associated with immunizations with various proposed mechanisms, including overactivation of the immune system and production of antibodies against circulating platelets. ITP has also been associated with several viral infections, including HCV, HIV, and most recently, active SARS-CoV-2 infection. Here, we present a case of a 52-year-old male with no past medical history who sought evaluation with his primary care physician for upper and lower extremity ecchymosis of one week duration. Outpatient laboratory studies were notable for severe isolated thrombocytopenia with platelet count of 8 × 10^9/L. Interestingly, he received the Johnson and Johnson COVID-19 vaccine 16 days prior to his presentation. Clinical work up and laboratory investigations led to the diagnosis of ITP.
format Article
id doaj-art-e3e2fa57d1be40cbadb698cf3faa7f1a
institution Kabale University
issn 2090-6579
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Case Reports in Hematology
spelling doaj-art-e3e2fa57d1be40cbadb698cf3faa7f1a2025-02-03T05:50:44ZengWileyCase Reports in Hematology2090-65792022-01-01202210.1155/2022/7208401Severe Thrombocytopenia Two Weeks Following Immunization with the Janssen Ad26.CoV2.S VaccineBana Antonios0Markie Zimmer1Emma Herrman2Ramona Berghea3Department of Internal MedicineDepartment of Internal MedicineDepartment of Internal MedicineDepartment of Internal MedicineImmune thrombocytopenia (ITP) has been associated with immunizations with various proposed mechanisms, including overactivation of the immune system and production of antibodies against circulating platelets. ITP has also been associated with several viral infections, including HCV, HIV, and most recently, active SARS-CoV-2 infection. Here, we present a case of a 52-year-old male with no past medical history who sought evaluation with his primary care physician for upper and lower extremity ecchymosis of one week duration. Outpatient laboratory studies were notable for severe isolated thrombocytopenia with platelet count of 8 × 10^9/L. Interestingly, he received the Johnson and Johnson COVID-19 vaccine 16 days prior to his presentation. Clinical work up and laboratory investigations led to the diagnosis of ITP.http://dx.doi.org/10.1155/2022/7208401
spellingShingle Bana Antonios
Markie Zimmer
Emma Herrman
Ramona Berghea
Severe Thrombocytopenia Two Weeks Following Immunization with the Janssen Ad26.CoV2.S Vaccine
Case Reports in Hematology
title Severe Thrombocytopenia Two Weeks Following Immunization with the Janssen Ad26.CoV2.S Vaccine
title_full Severe Thrombocytopenia Two Weeks Following Immunization with the Janssen Ad26.CoV2.S Vaccine
title_fullStr Severe Thrombocytopenia Two Weeks Following Immunization with the Janssen Ad26.CoV2.S Vaccine
title_full_unstemmed Severe Thrombocytopenia Two Weeks Following Immunization with the Janssen Ad26.CoV2.S Vaccine
title_short Severe Thrombocytopenia Two Weeks Following Immunization with the Janssen Ad26.CoV2.S Vaccine
title_sort severe thrombocytopenia two weeks following immunization with the janssen ad26 cov2 s vaccine
url http://dx.doi.org/10.1155/2022/7208401
work_keys_str_mv AT banaantonios severethrombocytopeniatwoweeksfollowingimmunizationwiththejanssenad26cov2svaccine
AT markiezimmer severethrombocytopeniatwoweeksfollowingimmunizationwiththejanssenad26cov2svaccine
AT emmaherrman severethrombocytopeniatwoweeksfollowingimmunizationwiththejanssenad26cov2svaccine
AT ramonaberghea severethrombocytopeniatwoweeksfollowingimmunizationwiththejanssenad26cov2svaccine